Crystals of monosodium urate (MSU) provide a dose-dependent stimulus for the production by human blood monocytes of tumor necrosis factor (TNF), a cytokine with proinflammatory properties; TNF activity was inhibited selectively by monoclonal antibody to TNF alpha. Biologically active cell-associated TNF activity peaked at 3 h and was exceeded at 6 h by extracellular activity, which peaked at 12-18 h. Comparable kinetics were observed with immunoreactive TNF alpha. TNF alpha mRNA accumulation in monocytes stimulated with MSU crystals appeared as a single peak at 2-4 h, kinetics compatible with rapid production ofa short half-life transcript. In contrast, crystals of calcium pyrophosphate or of hydroxyapatite did not stimulate significant production of TNF or of message.
Introduction
Acute gouty arthritis is thought to be an inflammatory response to microcrystals ofmonosodium urate (MSU)' that precipitate in joint tissues from supersaturated body fluids or are shed from preexisting articular deposits (for review, see 1). Until the last decade, urate crystals were thought to interact primarily with PMN, the cells within which they are found in Dr. di Giovine's and Dr. Duffs present address is: Section ofMolecular Medicine, University Department of Medicine, Royal Hallamshire Hospital, Sheffield S 10 2JF, UK, where reprint requests should be addressed to Dr. di Giovine.
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Useful as far as it went, this scheme could account neither for the initiation ofgouty inflammation, free crystals also being present in tissues between inflammatory attacks, nor for associated systemic features (fever, leukocytosis, generation of acute-phase reactants), which appeared, as of the early 1980s (3, 4) , no longer attributable to PMN. These considerations led us initially to examine the release of "endogenous pyrogen" (EP; the original designation for fever-producing cytokines) from monocytes and macrophages exposed to MSU (5, 6) . We found that the activation process for EP production was dose dependent, did not require phagocytosis of the crystals, was independent of serum factors or of mediation by other blood leukocytes, and could not be attributed to contamination ofthe crystal by bacterial endotoxin (LPS) (5) . We then examined in detail IL-I (7), a pyrogenic cytokine with multiple biological actions, finding high levels of lLl beta released.
Tumor necrosis factor (TNF)/cachectin, the subject ofthis report, is a 17-kD inducible peptide (8) produced mainly by activated macrophages, with biological actions very similar to those of IL-1 (9) , although it is the product of a different gene (10) and acts via a distinct set ofcell surface receptors (1 1, 12) . Systemic properties of TNF include induction of fever (13) , acute phase response (14) , and metabolic (15) and hemodynamic changes (16, 17) . Of relevance to the pathogenesis of inflammatory arthritis andjoint destruction, TNF alpha stimulates cartilage (18) and bone (19) resorption, activates synovial cells to produce proinflammatory mediators (20) , and increases expression of MHC (21) and adhesion (22) molecules. It also induces the production of other macrophage-derived cytokines, such as IL-l (13), IL-6 (23), and IL-8 (24) . TNF alpha has been found in symptomatic joints of arthritic patients and has been implicated in acute and chronic arthritic diseases (25) (26) (27) .
Taken together with earlier studies, the results ofthis work support an expanded view of gouty inflammation (6) (Gibco Ltd., Paisley, UK), while L929 cell culture and cytotoxicity assays were performed in MEM medium (Sigma). Both media were supplemented with 2 mM glutamine and 5% heat-inactivated FCS (Gibco) unless otherwise stated.
Human recombinant (hr) TNF alpha and MAb to TNF alpha ("TNF-E") were kindly given by Dr. G. Adolf, Boehringer Institute, Wien, Austria. The specific neutralizing activity in the cytotoxicity assay was -300 ng hrTNF alpha/mg antibody (data not shown).
Cell culture. Blood from young healthy volunteers was collected in preservative-free heparin (Leo Laboratories Ltd., Aylesbury, UK) and immediately processed. Mononuclear cells were separated by gradient fractionation on Ficoll-Hypaque (pyrogen tested-Lymphoprep; Nyegaard Co., Oslo, Norway), and selected by adherence to plastic multiwell dishes (Nunc, Roskilde, Denmark). Medium was added to a final cell concentration of 106/ml. Cells (60-80% monocytes by morphological criteria) were cultured for different times in the presence or absence of test stimuli and the centrifuged supernatants were aliquoted and stored (representing extracellular fractions). The cells were subjected to three cycles ofrapid freeze-thawing in fresh medium (at initial volume) to obtain the cell-associated fraction. Extracellular and cell-associated fractions were stored in aliquots at -700C until tested.
Cultures for mRNA analysis were similarly prepared, and cells were removed by gentle scraping of the wells with a rubber policeman (Costar, Data Packaging Corp., Cambridge, MA) in ice-cold PBS. The cell suspension was washed twice in PBS and immediately processed.
Stimuli. Crystals of MSU, hydroxyapatite (HA), and calcium pyrophosphate dihydrate (CPPD) were prepared as previously described (6) . Crystal preparations were resuspended at 10 mg/ml in PBS, and tested by the Limulus gelation test for bacterial endotoxin (28) . We have shown previously (7) To standardize mRNA extraction and loading, we used a 708-bp PstI-DraI fragment from a p7B6 insert in pBr322 (from Dr. M. Feldmann, Sunley Research Centre, London), which codes for a cell cycleindependent species of mRNA (31) .
All fragments were 32P-labeled by random oligo priming (32) . After separation on Sephadex G50 (Pharmacia LKB Biotechnology, Uppsala, Sweden), cDNA probes were obtained at a sp act of 6-10 X 101 dpm/gg DNA.
In kinetic studies, total cytoplasmic RNA was prepared (33) from adherent mononuclear cells cultured for different times. At the end of incubation, cells were resuspended in ice-cold 10 mM Tris, I mM EDTA (pH 7.0), lysed by detergent, and nuclei were pelleted by centrifugation. Cytoplasmic preparations were extracted with phenol/chloroform and resuspended in 0.9 M NaCl/90 mM sodium citrate/7.4% formaldehyde for 15 min at 60°C. Cytoplasmic preparations were transferred onto nylon membranes (Hybond N; Amersham International, Amersham, UK) using a slot blot apparatus (Minifold II;
Schleicher & Schuell, Dassel, FRG). Membranes were exposed to UV and prehybridized for 8-20 h (50% formamide, 240 mM NaCl, 30 mM sodium citrate, 40 mM sodium phosphate, 0.02% Ficoll, 0.02% polyvinyl pyrrolidone, 0.02% BSA). Hybridization was carried out in fresh prehybridization solution to which denatured sheared calfthymus and 32P-labeled probe had been added. After 18-24 h at 370C, membranes were washed four times (15 min) in 0.1% SDS and decreasing salt concentration (from 0.3 M NaCl, 30 mM sodium citrate, to 15 mM NaCl, 1.5 mM sodium citrate). Blots were visualized by exposure of x-ray films (Agfa-Gevaert, Dunstable, UK) at -800C with intensifying screens for 4 h-4 d. To obtain quantitative data, we scanned autoradiographs at ODj50 in a densitometer (CS9000; Shimadzu Instruments, Kyoto, Japan) (calibration at X 16, integral of peak area = scanning densitometry [SD] units).
For Northern analysis, total cellular RNA was isolated using the guanidinium/phenol method (34) . Briefly, cellular proteins were disintegrated in 4M guanidine isothyocyanate, followed by an extraction with phenol, and equilibration in ice-cold Tris/acetate buffer, pH7.4. After two cycles of chloroform/isoamyl-alcohol (24:1) extractions, total RNA in the final aqueous phase was precipitated in 50% isopropanol at 40C. The pellets obtained were washed in 70% ethanol and resuspended in 10 mM 3-[N-morpholino]-2-hydroxypropanesulfonic acid (MOPS) buffer.
Samples were size-fractionated in agarose/formaldehyde gels (1.2% Seakem agarose, 6.7% formaldehyde, 20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA), and transferred overnight to nylon membranes by capillary blotting. All subsequent steps were as previously indicated for total cytoplasmic RNA preparations.
TNF in tophus. Fresh tophaceous material was obtained by needle aspiration from an interphalangeal joint. The mass was immediately fragmented and resuspended in 0.5 ml serum-free RPMI 1640 medium, and then pelleted by centrifugation. Supernatant was aspirated and tested for immunoreactive TNF alpha. The pellet was resuspended in fresh medium and fractionated on a Ficoll density gradient. Cells (80% polymorphonuclear, 15% lymphocytes, 5% monocytes by morphological criteria) were cultured for 18 h in RPMI 1640 (I07 cells/ml) and supernatants tested for TNF alpha.
Results
Induction ofTNF biological activity by crystals. Human blood adherent mononuclear cells were incubated in the presence or absence of MSU, HA, or CPPD crystals for 18 h. Supernatants were collected and tested for TNF biological activity (Fig. 1 Table I show selective inhibition of L929 cytotoxicity, indicating that the cytotoxicity observed was mediated by TNF alpha.
TNF alpha production in synovial cells. Freshly isolated human RA synovial fluid mononuclear cells (MNC) spontaneously released immunoreactive TNF alpha in a 20-h incubation (Fig. 2 A) . This is likely to reflect activation in vivo rather than inadvertent activation during separation procedures, since autologous blood MNC produced no TNF activity without prior stimulation (data not shown). The herent mononuclear cells. Fractions were collected at different time points (0-18 h) and tested for TNF activity by bioassay (Fig. 3 A) . After an initial peak of cell-associated TNF activity at 3 h after MSU, extracellular TNF at 6 h exceeded cell-associated TNF, to reach a maximum at 12-18 h. Comparable kinetics were obtained when immunoreactive TNF alpha was measured (Fig. 3 B) , with 90% of TNF alpha translocated at 18 h. In these kinetic experiments, cells stimulated with HA and CPPD did not express TNF biological activity, either cell associated or in the supernatant. Unstimulated cells similarly failed to express TNF activity or immunoreactive TNF alpha, indicating the absence of a preformed TNF alpha protein pool in resting cells.
Crystal-induced TNF alpha mRNA accumulation. Cells incubated for 4 h in medium or in the presence of HA or CPPD crystals failed to express TNF alpha mRNA (Fig. 4) . Cells induced with LPS (100 ng/ml) or MSU crystals (0.4 mg/ml) accumulated an mRNA species that migrated in the 1.5-kb region and hybridized with radiolabelled TNF alpha cDNA.
Kinetics of TNF alpha mRNA accumulation were determined by slot blot analysis (Figs. 5 and 6 ). In the same cultures, supernatant TNF alpha was measured by RIA (Fig. 6) lated detectable levels of TNF alpha mRNA by 6 h and at 20-30 h. Surprisingly, this was not associated with TNF alpha protein in the supernatants. In contrast, MSU crystals stimulated early accumulation of TNF alpha mRNA, and immunoreactive TNF alpha in the supernatant (Fig. 6) .
TNFalpha in tophus. Supernatants offresh tophaceous material contained 220 pg/ml TNF alpha (Fig. 2 B) , indicating that TNF was present within the gouty tophus in vivo. Cells obtained from the tophus produced 120 pg immunoreactive TNF alpha/107 cells after in vitro culture of 18 h (Fig. 2 B) .
Discussion
In this study we found that MSU crystals provide a dose-dependent stimulus for TNF production in human monocytes (Fig.  1) . At supraoptimal concentrations of MSU crystals it is likely that reduced TNF alpha production was a consequence of the experiments (below) was not confirmed. CPPD crystals showed no TNF-inducing activity. We also found spontaneous production of TNF alpha by RA synovial fluid adherent mononuclear cells (Fig. 2 A) . TNF production could be further stimulated by addition of MSU to the cells, while HA crystals had no effect. Ex vivo evidence for the relevance ofTNF alpha in gouty arthritis was found in fresh tophaceous material from an interphalangeal joint (Fig. 2 B) . It contained significant amounts of immunoreactive TNF alpha, and cells obtained from the tophus continued to release this cytokine over 18 h incubation (120 pg TNF alpha/ 107 cells/ml).
The failure of HA and CPPD to induce significant TNF synthesis was confirmed in time-course experiments where neither crystal type induced either cell-associated TNF biological activity (Fig. 3) or mRNA accumulation (Figs. 5 and 6 ). These two crystals also do not induce significant synthesis of IL-I in our hands (7) .
In contrast, LPS-free crystals of MSU induced time-dependent accumulation of TNF alpha in both cell-associated and extracellular compartments, with detectable levels at 3 h in cell lysates, followed by extracellular translocation of biologically active TNF alpha, found mainly in the supernatants at 9-18 h (extracellular TNF alpha, 2.24 ng/ml; 90.5% of the total).
In these cultures, immunoreactive TNF alpha generally followed the pattern ofdistribution of TNF bioactivity. However, discrepancies were noticed at late stages ofincubation, perhaps indicating the presence of cytotoxicity unrelated to TNF alpha and/or production of biological inhibitors (26). It is of interest that we found no evidence ofTNF accumulation in the cell-as- sociated fractions, suggesting that the reported form of membrane-associated TNF alpha (35) could only exist as a transient event in our conditions. TNF alpha mRNA accumulation appears as a single peak at 2-4 h (Fig. 6) . In studies using phorbol stimulation (36) a similar monophasic response was observed but with maximum levels at a later time (12-16 h) . The mRNA kinetics are compatible with rapid production of a short half-life transcript. Unstimulated cells accumulated low levels of TNF alpha mRNA at late stages ofincubation but this was not followed by translocation of immunoreactive protein. This may represent untranslated mRNA as has been reported for TNF alpha in macrophages from C3H/HeJ mice (37) . The kinetics ofproduction of biologically active TNF alpha are remarkably similar to those of IL-1 alpha and IL-1 beta (38) , and would argue against sequential induction of one cytokine by another. The peak level of total TNF produced in response to MSU crystals (2.44 ng/ ml) was lower than those of IL-1 in the same experiment (IL-I alpha, 9.9 ng/ml; IL-l beta, 10.9 ng/ml). The dose-response relation of MSU concentration to total production of TNF alpha, IL-1 alpha, or IL-1 beta was similar in all three cases, with optimal stimulation occurring between 0.8 and 1.2 mg/ml MSU crystals (38) .
TNF and IL-1 have independent proinflammatory and immunopotentiating activities and each could therefore contribute to the response to MSU crystal deposition. Both TNF and IL-1 are powerful stimuli ofIL-6 (23) and IL-8 (24) production, which could (respectively) account for the pronounced acute phase response and neutrophil chemotaxis associated with MSU crystal deposition. Both IL-6 and IL-8 have been found in supernatants after stimulation ofmonocytes with urate crystals (39, 40).
The likely clinical correlates of these considerations, formulated for "EP/IL-1" (6), but expandable to include TNF alpha and the other cytokines that it and IL-1 engender, can be summarized as follows: (a) Initiation ofacute gouty arthritis. Urate crystals, brought into contact with mononuclear phagocytes within the joint, can generate cytokines chemotactic for PMN. When the latter cells encounter ingestible particles (urate crystals) they can propagate and amplify the inflammatory response (see Introduction), producing acute gout. As crystals may be present when inflammation is not, they would seem to be the fuel for the inflammatory engine, not the spark; hence acute gout is properly "crystal associated" rather than "crystal induced" (1) . Although adsorbed material might affect the phlogistic potential of crystals (2), they still have to be "told" when to change their coats; i.e., there must be a prior series of controls. Candidates for the inflammatory sparks that introduce crystals to resident mononuclear phagocytes would include local trauma, gross or micro-, whose effects in normal individuals (those without crystal "fuel") would quickly fade or remain subclinical. (b) Acutepolyarticulargout. Cytokines generated in gouty joints can disseminate to other areas of the body, as evidenced by systemic manifestations such as fever (hypothalamus), leukocytosis (bone marrow), and acute phase reactants (liver). They are therefore prime suspects as the messengers that result in the typical intense inflammation that one sees in overlying skin, and that sometimes lead other joints to become inflamed, as if by "contagion." A logical corollary to the latter point is that the inciting inflammatory cytokines may originate in extraarticular sites of trauma, inflammation, or infection, thus explaining why both acute gouty arthritis and pseudogout are often superimposed upon trauma or infection elsewhere, and why polyarticular gout has a predilection for elderly, debilitated, often febrile individuals. Cytokines arriving in a joint charged with CPPD crystals may be especially important in initiating pseudogout, as those crystals seem not to induce production either of TNF alpha, as shown here, or of IL-1 (7). (c) Tophi and chronic tophaceous gout. Tophi contain IL-1-producing cells (mononuclear phagocytes) in close proximity to IL-1 inducers (urate crystals), surrounded by cytokineinducible material (fibrous tissue). Sometimes tophi reside in characteristic sclerotic-rimmed punched-out areas formerly occupied by material (cartilage and bone) whose resorption is also inducible by cytokines. In chronic tophaceous gout, through persistent stimulation of mononuclear phagocytes, rampant tophaceous material in and about joints may engender chronic inflammatory processes similar to those seen in rheumatoid arthritis, which this condition resembles clinically.
Thus, in view of the biological actions of TNF and IL-1, their reported synergy in several human systems (41) (42) (43) and the possibility of mutual induction (13, 44), we believe that stimulation of IL-I and TNF production by MSU crystals may be a crucial link between crystal deposition and both the acute and chronic inflammatory reactions of gouty arthritis.
